Mn Services Vermogensbeheer B.V. cut its holdings in PepsiCo, Inc. (NASDAQ:PEP – Free Report) by 2.2% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 531,769 shares of the company’s stock after selling 11,700 shares during the quarter. PepsiCo comprises about 0.6% of Mn Services Vermogensbeheer B.V.’s investment portfolio, making the stock its 27th biggest holding. Mn Services Vermogensbeheer B.V.’s holdings in PepsiCo were worth $90,427,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently bought and sold shares of the company. Global Wealth Strategies & Associates boosted its holdings in PepsiCo by 59.0% during the third quarter. Global Wealth Strategies & Associates now owns 159 shares of the company’s stock worth $27,000 after buying an additional 59 shares in the last quarter. Highline Wealth Partners LLC acquired a new position in shares of PepsiCo in the 3rd quarter worth $28,000. POM Investment Strategies LLC lifted its holdings in shares of PepsiCo by 141.3% during the second quarter. POM Investment Strategies LLC now owns 181 shares of the company’s stock valued at $30,000 after purchasing an additional 106 shares during the last quarter. Summit Securities Group LLC acquired a new position in shares of PepsiCo in the 2nd quarter valued at $30,000. Finally, Mattson Financial Services LLC purchased a new position in PepsiCo in the 2nd quarter worth about $34,000. 73.07% of the stock is owned by institutional investors and hedge funds.
PepsiCo Stock Up 0.3 %
NASDAQ PEP traded up $0.53 during trading on Monday, reaching $166.12. The company’s stock had a trading volume of 670,403 shares, compared to its average volume of 5,445,768. The company has a current ratio of 0.89, a quick ratio of 0.70 and a debt-to-equity ratio of 1.96. The stock has a market capitalization of $227.91 billion, a PE ratio of 24.42, a PEG ratio of 3.09 and a beta of 0.53. PepsiCo, Inc. has a 1-year low of $158.03 and a 1-year high of $183.41. The business has a 50-day moving average price of $173.03 and a 200-day moving average price of $172.25.
Analyst Upgrades and Downgrades
Several brokerages have commented on PEP. Deutsche Bank Aktiengesellschaft decreased their target price on shares of PepsiCo from $180.00 to $179.00 and set a “hold” rating for the company in a report on Wednesday, October 9th. TD Cowen downgraded shares of PepsiCo from a “buy” rating to a “hold” rating and cut their target price for the company from $190.00 to $183.00 in a research note on Thursday, October 10th. DZ Bank cut PepsiCo from a “buy” rating to a “hold” rating and set a $183.00 target price for the company. in a research report on Friday, July 19th. Wells Fargo & Company dropped their price target on PepsiCo from $175.00 to $170.00 and set an “equal weight” rating on the stock in a research report on Wednesday, July 10th. Finally, StockNews.com upgraded PepsiCo from a “hold” rating to a “buy” rating in a research report on Friday, October 25th. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat, PepsiCo currently has an average rating of “Hold” and a consensus target price of $183.92.
Read Our Latest Stock Report on PepsiCo
PepsiCo Company Profile
PepsiCo, Inc engages in the manufacture, marketing, distribution, and sale of various beverages and convenient foods worldwide. The company operates through seven segments: Frito-Lay North America; Quaker Foods North America; PepsiCo Beverages North America; Latin America; Europe; Africa, Middle East and South Asia; and Asia Pacific, Australia and New Zealand and China Region.
Further Reading
- Five stocks we like better than PepsiCo
- How Technical Indicators Can Help You Find Oversold StocksÂ
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- 3 Tickers Leading a Meme Stock Revival
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
- How to Calculate Stock Profit
- 3 Stocks That Are Potential Takeover Targets in 2025
Receive News & Ratings for PepsiCo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PepsiCo and related companies with MarketBeat.com's FREE daily email newsletter.